Reverse Takotsubo Cardiomyopathy After an Adverse Reaction to Alteplase Treated with Intravenous Epinephrine
- PMID: 41125909
- PMCID: PMC12680817
- DOI: 10.1007/s40119-025-00432-6
Reverse Takotsubo Cardiomyopathy After an Adverse Reaction to Alteplase Treated with Intravenous Epinephrine
Abstract
Takotsubo (stress) cardiomyopathy (TTC) is an uncommon acute heart failure syndrome characterized by transient hypocontractility that usually affects a circumferential segment of the myocardium along the heart's apicobasal axis and spans multiple coronary artery territories. Classically, TTC occurs after an intense physical or emotional insult and is thought to be caused by catecholamine toxicity. The most frequent anatomic variant presents with apical hypokinesis and basal hyperkinesis, but the hypocontractility may also localize to the mid-ventricle or base, also known as "reverse TTC." Here, we describe a middle-aged woman who developed profound acute hypoxemic respiratory failure and mixed cardiogenic-distributive shock after an adverse reaction to alteplase treated with high-dose epinephrine. The patient was found to have a severely depressed left ventricular ejection fraction (10-15%) with apex-sparing hypokinesis and no evidence of obstructive coronary artery disease, consistent with reverse TTC. The patient's ejection fraction recovered to the normal range within days with supportive measures. This case highlights the distinctive echocardiographic features of this rare, potentially life-threatening form of TTC.Videos are available for this article.
Keywords: Alteplase; Echocardiography; Epinephrine; Reverse takotsubo cardiomyopathy; Stress cardiomyopathy.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of Interest: Dr. Robert P. Giugliano discloses research grant support to the Brigham and Women’s Hospital from Amgen to conduct clinical trials; honoraria for lectures and continuing medical education (CME) programs from Amgen, Medical Education Resources, Merck, and Pfizer; and honoraria for consulting from Amgen, Bayer, Janssen, Novartis, and Pfizer. Dr. Robert P. Giugliano is a former Editor-in-Chief of Cardiology and Therapy. Dr. Charles G. Kinzig, Dr. Matthew R. Carey, and Dr. Lauren P. Waldman have nothing to disclose. Ethical Approval: The patient presented in this case report granted permission for publication of her clinical course. We thank her for her participation.
Figures
References
-
- Sato H, Tateishi H, Uchida T. Takotsubo-type cardiomyopathy due to multivessel spasm. In: Kodama K, Haze K, Hon M, editors. Clin Asp Myocard Inj Ischemia Heart Fail. Tokyo: Kagakuhyouronsha Co.; 1990. p. 56–64.
LinkOut - more resources
Full Text Sources
Miscellaneous
